DE2521113A1 - Cycloaliphatische derivate von 3.3-diphenylpropylamin - Google Patents

Cycloaliphatische derivate von 3.3-diphenylpropylamin

Info

Publication number
DE2521113A1
DE2521113A1 DE19752521113 DE2521113A DE2521113A1 DE 2521113 A1 DE2521113 A1 DE 2521113A1 DE 19752521113 DE19752521113 DE 19752521113 DE 2521113 A DE2521113 A DE 2521113A DE 2521113 A1 DE2521113 A1 DE 2521113A1
Authority
DE
Germany
Prior art keywords
compounds according
diphenylpropylamine
meaning
hydrochloride
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752521113
Other languages
German (de)
English (en)
Inventor
Massimo Carissimi
Giampaolo Picciola
Franco Ravenna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maggioni and C SpA
Original Assignee
Maggioni and C SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maggioni and C SpA filed Critical Maggioni and C SpA
Publication of DE2521113A1 publication Critical patent/DE2521113A1/de
Withdrawn legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19752521113 1974-05-15 1975-05-13 Cycloaliphatische derivate von 3.3-diphenylpropylamin Withdrawn DE2521113A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2270974 1974-05-15

Publications (1)

Publication Number Publication Date
DE2521113A1 true DE2521113A1 (de) 1976-03-18

Family

ID=11199496

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752521113 Withdrawn DE2521113A1 (de) 1974-05-15 1975-05-13 Cycloaliphatische derivate von 3.3-diphenylpropylamin

Country Status (4)

Country Link
JP (1) JPS5123248A (ru)
DE (1) DE2521113A1 (ru)
FR (1) FR2270853B1 (ru)
GB (1) GB1461240A (ru)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US7732413B2 (en) 2003-03-07 2010-06-08 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7741289B2 (en) 2003-03-07 2010-06-22 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2011069038A2 (en) 2009-12-03 2011-06-09 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2013138352A1 (en) 2012-03-15 2013-09-19 Synergy Pharmaceuticals Inc. Formulations of guanylate cyclase c agonists and methods of use
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
EP2810951A2 (en) 2008-06-04 2014-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2014197720A2 (en) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase c, method of making and using same
EP2998314A1 (en) 2007-06-04 2016-03-23 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482956A1 (fr) * 1980-05-22 1981-11-27 Synthelabo Cyclohexylalkylamines, leurs procedes de preparation et leur application en therapeutique

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US7732413B2 (en) 2003-03-07 2010-06-08 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7741289B2 (en) 2003-03-07 2010-06-22 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2998314A1 (en) 2007-06-04 2016-03-23 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2810951A2 (en) 2008-06-04 2014-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2923706A1 (en) 2009-12-03 2015-09-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia
WO2011069038A2 (en) 2009-12-03 2011-06-09 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2013138352A1 (en) 2012-03-15 2013-09-19 Synergy Pharmaceuticals Inc. Formulations of guanylate cyclase c agonists and methods of use
EP3708179A1 (en) 2012-03-15 2020-09-16 Bausch Health Ireland Limited Formulations of guanylate cyclase c agonists and methods of use
EP4309673A2 (en) 2012-03-15 2024-01-24 Bausch Health Ireland Limited Formulations of guanylate cyclase c agonists and methods of use
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2014197720A2 (en) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
FR2270853A1 (ru) 1975-12-12
GB1461240A (en) 1977-01-13
FR2270853B1 (ru) 1978-09-08
JPS5123248A (en) 1976-02-24

Similar Documents

Publication Publication Date Title
DE2521113A1 (de) Cycloaliphatische derivate von 3.3-diphenylpropylamin
DE1620704A1 (de) Verfahren zur Herstellung von Indolizinverbindungen
DE2227022C2 (de) Hexamethylendiamin-Verbindungen und deren Verwendung
DE1103342B (de) Verfahren zur Herstellung neuer 1, 2-Diphenyl-3, 5-dioxo-1, 2, 4-triazolidin-Derivate
CH441291A (de) Verfahren zur Herstellung von organischen Aminen
AT238180B (de) Verfahren zur Herstellung neuer Pyrrolidinverbindungen
AT339277B (de) Verfahren zur herstellung von neuen 11-amino-benzo(b) bicyclo (3,3,1)nona-3,6a(10a)dienen und deren saureadditionssalzen
DE1595903C (de) 1-Substituierte 2,6-Dimethyl-4-phenylpiperazine
AT238186B (de) Verfahren zur Herstellung neuer Pyrrolidinverbindungen
DE2058237C (ru)
AT256823B (de) Verfahren zur Herstellung von neuen heterocyclischen Benzamidoverbindungen und ihren Salzen
AT219583B (de) Verfahren zur Herstellung von disubstituierten Carbonsäurehydraziden
AT274788B (de) Verfahren zur Herstellung von neuen N-(Hydroxycyclohexyl)-halogen-aminobenzylaminen und deren Säureadditionssalzen
AT251559B (de) Verfahren zur Herstellung von neuen Phenylisopropylaminen und deren Salzen
AT272301B (de) Verfahren zur Herstellung von neuen basischen, tricyclischen Verbindungen und deren Salzen
AT213890B (de) Verfahren zur Herstellung neuer 3,5-Dioxo-1,2,4-triazolidine
AT206890B (de) Verfahren zur Herstellung von neuen tertiären Aminen
DE1518549A1 (de) Verfahren zur Herstellung neuer Phenylcyclohexylalkylamine und ihrer Salze
AT221087B (de) Verfahren zur Herstellung neuer, basischer Indol-Derivate
AT210435B (de) Verfahren zur Herstellung von neuen Ferrocenderivaten
AT201580B (de) Verfahren zur Herstellung neuer, sekundärer Amine
AT266075B (de) Verfahren zur Herstellung von neuen Sulfonaniliden und deren Säureadditions- und Metallsalzen
AT226710B (de) Verfahren zur Herstellung von neuen Dihydrochinoxalonen-(2) und von deren Salzen
AT219577B (de) Verfahren zur Herstellung von neuen Triaminen und deren salzartigen Abkömmlingen
AT334883B (de) Verfahren zur herstellung von neuen alfa-(1-bis-arylalkylaminoalkyl)-aralkoxybenzylalkoholen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8115 Request for examination void
8110 Request for examination paragraph 44
8139 Disposal/non-payment of the annual fee